Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Net Cash Flow (2018 - 2025)

Historic Net Cash Flow for ImmunoTech (AIM) over the last 11 years, with Q3 2025 value amounting to $1.9 million.

  • ImmunoTech's Net Cash Flow rose 17089.81% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 10997.98%. This contributed to the annual value of -$3.7 million for FY2024, which is 8270.57% up from last year.
  • According to the latest figures from Q3 2025, ImmunoTech's Net Cash Flow is $1.9 million, which was up 17089.81% from -$422000.0 recorded in Q2 2025.
  • ImmunoTech's 5-year Net Cash Flow high stood at $1.9 million for Q3 2025, and its period low was -$9.8 million during Q4 2023.
  • In the last 3 years, ImmunoTech's Net Cash Flow had a median value of -$2.1 million in 2024 and averaged -$2.2 million.
  • Data for ImmunoTech's Net Cash Flow shows a peak YoY increase of 17089.81% (in 2025) and a maximum YoY decrease of 26293.44% (in 2025) over the last 5 years.
  • Over the past 3 years, ImmunoTech's Net Cash Flow (Quarter) stood at -$9.8 million in 2023, then soared by 108.0% to $786000.0 in 2024, then soared by 138.04% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, -$422000.0 for Q2 2025, and -$803000.0 during Q1 2025.